Effect of HMG-CoA reductase inhibitors (statins) on bone mineral density

Journal of Clinical Densitometry

Volumn 5, Issue 2, 2002, Pages 151-158

  Funkhouser, Holly L ^a,b   Adera, Tilahun ^b   Adler, Robert A ^a,b,c  

^a McGuire Veteran's Administration Hospital   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bone mineral density; Hydroxymethylglutaryl CoA reductase inhibitors; Osteoporosis

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STATIN; VITAMIN;

ADULT; AGE; AGED; ANALYTIC METHOD; ARTICLE; AUTOMATION; BODY MASS; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DRUG EFFECT; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PHARMACY; PRIORITY JOURNAL; RACE; REGRESSION ANALYSIS; RISK ASSESSMENT; SPINE; STATISTICAL SIGNIFICANCE; TIME; FEMUR; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; BONE DENSITY; FEMALE; FEMUR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; OSTEOPOROSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SPINE;

EID: 0036021835     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1385/JCD:5:2:151     Document Type: Article

References (16)

1. Effect of statins on risk of coronary diseases: A meta-analysis of randomized controlled trials
2. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Survival Study
3. Osteoporosis: Part 1. Evaluation and assessment
4. Oral statins and increased bone mineral density in postmenopausal women
5. Do statins prevent both cardiovascular disease and fracture?
6. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients
7. HMG-CoA reductase inhibitors and the risk of fractures
8. Stimulation of bone formation in vitro and in rodents by statins
9. Effect of pravastatin on frequency of fracture in the LIPID study: Secondary analysis of a randomized controlled trial
10. Statin use, bone mass and fracture: An analysis of two prospective studies
11. Inhibitors of hydroxymethyl-glutaryl-coenzyme A reductase and risk fracture among older women
12. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients
13. Use of statins and risk of fractures
14. An update on the diagnosis and assessment of osteoporosis with densitometry
15. Prescriptions and adherence to statins of patients with coronary artery disease and hypercholesterolemia